卡比海运 KEX 深 沪
等待开盘 12-15 09:30:00 美东时间
111.01
-1.080
-0.96%
华盛通- 最 高112.815
- 今 开112.71
- 成交量 67.68万股
- 最 低 110.00
- 昨 收 112.09
- 总市值 60.17亿
- 52周最高 122.50
- 市盈率 静 22.60
- 换手率 1.25%
- 52周最低 79.515
- 委 比 -87.76%
- 总股本 5420.00万
- 历史最高 132.205
- 量 比 0.99
- 振 幅 2.51%
- 历史最低 32.76
- 每 手 1
- 风险率 10.08%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Verrica Pharmaceuticals Announces Private Placement Financing of $50 Million to Retire Debt and Extend Cash Runway
Verrica Pharmaceuticals announced a $50 million PIPE financing to retire debt with OrbiMed and fund operations into mid-2027. New and existing investors, including Caligan Partners LP and PBM Capital, participated, with Caligan earning a board seat. Proceeds will support commercialization of YCANTH for molluscum contagiosum and VP-315 for basal cell carcinoma, as well as a global Phase 3 program for common warts. The financing strengthens Verrica...
11-24 13:00
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
Nyxoah SA has secured up to $77 million in financing commitments to drive U.S. commercialization of its Genio system for treating obstructive sleep apnea (OSA). The funding includes a private placement of €22 million, a registered direct offering of approximately $5.6 million, and a convertible bond of up to €45 million. Proceeds will support commercialization efforts, clinical data gathering, R&D for system upgrades, and other corporate purposes...
11-13 21:36
美股大行评级 | 最高325美元！10家机构集体上调AMD目标价；Pinterest遭14家大行下调目标价；大行对优步目标价分歧大，5家下调5家上调
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从3美元升至9美元；HC Wainwright & Co.：上调CervoMed评级至"买入"，目标价从11美元升至25美元
11-06 09:55
Citigroup Upgrades Kirby to Buy, Raises Price Target to $128
Citigroup analyst Ben Mohr upgrades Kirby (NYSE:KEX) from Neutral to Buy and raises the price target from $110 to $128.
11-05 20:10
Lightbridge Presents Three Technical Papers on Lightbridge Fuel Technology at American Nuclear Society’s TopFuel 2025 Conference
<p>Lightbridge Corporation presented three technical papers at the American Nuclear Society’s TopFuel 2025 conference in Nashville, Tennessee. The papers highlighted advancements in Lightbridge’s proprietary nuclear fuel technology, focusing on design, fabrication, and performance assessment to enhance reactor safety, efficiency, and sustainability. The studies included a comparison of Lightbridge Fuel™ against conventional uranium dioxide fuel, ...
11-05 14:00
美股大行评级 | 最高350美元！16家大行上调谷歌目标价！Meta遭12家大行下调目标价；潜在涨幅1456.29%！NRX Pharmaceuticals获Ascendiant Capital升目标价至47美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从46美元升至47美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从27美元升至31美元
10-31 10:25
10月31日外盘头条：苹果Q3营收略超预期 奈飞分拆股票 英伟达再投AI初创公司 美政府停摆航空业承压
全球财经媒体昨夜今晨共同关注的头条新闻主要有： 1、美国政府停摆致航空业承压，联合航空与美国航空CEO将与万斯会面 2、苹果三...
10-31 05:30
Earnings Scheduled For October 29, 2025
Companies Reporting Before The Bell • OppFi (NYSE:OPFI) is expected to report q...
10-29 19:11
Kirby Q3 EPS $1.65 Beats $1.62 Estimate, Sales $871.161M Beat $846.209M Estimate
Kirby (NYSE:KEX) reported quarterly earnings of $1.65 per share which beat the analyst consensus estimate of $1.62 by 1.85 percent. This is a 6.45 percent increase over earnings of $1.55 per share from the same period
10-29 19:03
